$XTLバイオファーマシューティカルズ (XTLB.US)$XTL Biopharmaceuticals Enters Agreement To Acquire AI Web Data Company The Social Proxy; Secures $1.5M In Private Placement. XTL Biopharmaceuticals Will Issue ADSs Representing 44.6% of Issued and Outstanding Shr Cap to Hldrs of Social Proxy
$XTLバイオファーマシューティカルズ (XTLB.US)$closing out on this one, holding$アルタミラ セラピューティクス (CYTO.US)$all week for the squeeze. some sources im seeing say CYTO only has a 325k float since the RS last december. makes it very easy to manipulate, but can also easily 10x
XTL Biopharmaceuticals Leverages AI in Healthcare with The Social Proxy Acquisition. In an unexpected yet strategic move, XTL Biopharmaceuticals Ltd (NASDAQ: XTLB) announced its acquisition of The Social Proxy, a decision that has sent ripples through both the biopharmaceutical and tech industries. This acquisition not only marks XTL's ambitious expansion into the AI and web data sphere but also signific...
XTLバイオファーマシューティカルズに関するコメント
In an unexpected yet strategic move, XTL Biopharmaceuticals Ltd (NASDAQ: XTLB) announced its acquisition of The Social Proxy, a decision that has sent ripples through both the biopharmaceutical and tech industries. This acquisition not only marks XTL's ambitious expansion into the AI and web data sphere but also signific...
まだコメントはありません